|
News
Participation in the 2nd ASEAN Pathology Conference 2025
|
News
Participation in the 2nd Annual Congress of the Asian Society of Digital Pathology (ASDP 2025 Mumbai)
|
News
【Medmain’s AI-Powered Pathology Cloud System “PidPort” implemented at Ha Dong General Hospital in Vietnam】
|
News
【Announcement】The 2nd ASEAN Pathology Conference
|
News
【Announcement】The 2nd Annual Congress of the Asian Society of Digital Pathology (ASDP)
|
News
Medmain and SMC Sign Partnership to Launch AI-Powered Pathological Diagnosis Support in Vietnam
|
News
Medmain has signed a MOU with major Vietnamese medical institutions to promote the use of AI and the digitalization of pathological diagnosis
|
News
Our CEO Osamu Iizuka had a presentation at the 11th Digital Pathology & AI Congress USA
|
News
Our CEO Osamu Iizuka will give a presentation at the 11th Digital Pathology & AI Congress USA
|
News
Medmain Acquires ISO13485 Certification, an International Standard for Medical Device Quality Management Systems
|
News
Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play
|
News
Announcement of Participation in the Japan Night – 43rd Annual J.P. Morgan Healthcare Conference
|
News
Medmain Acquires ISO/IEC 27001 Certification for an Information Security Management System
|
News
Our CEO Osamu Iizuka had a presentation at Korea-Japan Startup Founder’s Day!
|
News
Notice of New Year Holidays
|
News
We participated in the 8th Digital Pathology & AI Congress Asia 2024!
|
News
Notice of Acquisition of a First-Class Marketing License for Medical Devices
|
News
【Announcement of Participation in the 8th Digital Pathology & AI Congress Asia 2024】
|
News
We are on the stage in Silicon Valley; that Japan Innovation Campus, by the Ministry of Economy, Trade, and Industry of Japan, for the Japanese startups
|
News
Promoting the Social Implementation of Pathological AI Developed by JP-AID and the University of Tokyo
|
News